No description
-
2007 (v1)PublicationUploaded on: April 14, 2023
-
2006 (v1)Publication
No description
Uploaded on: March 31, 2023 -
2003 (v1)Publication
No description
Uploaded on: April 14, 2023 -
2002 (v1)Publication
No description
Uploaded on: April 14, 2023 -
2003 (v1)Publication
No description
Uploaded on: April 14, 2023 -
2007 (v1)Publication
No description
Uploaded on: March 31, 2023 -
2014 (v1)Publication
No description
Uploaded on: April 14, 2023 -
2015 (v1)Publication
No description
Uploaded on: April 14, 2023 -
2006 (v1)Publication
Recent evidence indicates that cancer cells express chemokine (CK) receptors and that their signaling is crucial for tumor proliferation, migration, and angiogenesis. The profiles of expression of CXC CK receptors (CXCR1-5) and their main ligands (growth-related oncogene, GRO1-2-3/CXCL1-2-3; interleukin 8, IL-8/CXCL8; monokine-induced...
Uploaded on: April 14, 2023 -
1996 (v1)Publication
No description
Uploaded on: April 14, 2023 -
2011 (v1)Publication
No description
Uploaded on: March 31, 2023 -
2006 (v1)Publication
No description
Uploaded on: March 31, 2023 -
2016 (v1)Publication
No description
Uploaded on: April 14, 2023 -
2013 (v1)Publication
Cancer stem cells (CSCs) or tumor initiating cells (TICs) drive glioblastoma (GBM) development, invasiveness and drug resistance. Distinct molecular pathways might regulate CSC biology as compared to cells in the bulk tumor mass, representing potential therapeutic targets. Chemokine CXCL12 and its receptor CXCR4 control proliferation, invasion...
Uploaded on: April 14, 2023